Clinical Trials Browser

Phase 2 × Eflornithine × Tumor-Agnostic × Clear all

NCT01636128 2014-07-30

Urinary Biomarker Study With Sulindac and Difluoromethylornithine

Phase 2 Withdrawn

Neoplasms